Jun 24, 2015
By Pharmaceutical Technology Editors
Juniper Pharma Services has entered into a long-term collaboration with OxSonics to support the development, scale-up, and GMP manufacturing of OxSonics’ proprietary sono-sensitive particles.
Jun 09, 2015
By Pharmaceutical Technology Editors
The product, marketed as Sirdupla in the United Kingdom, is the generic version of GSK’s beta agonist and corticosteroid combination treatment for asthma.
Jun 02, 2015
Pharmaceutical Technology
Box-Behnken modeling was used to optimize a resinate complex, to mask the taste of levocetirizine dihydrochloride and montelukast sodium in orally disintegrating tablets.
Jun 02, 2015
Pharmaceutical Technology
Successful drug delivery via a dry powder inhaler is determined by the API physicochemical properties, the formulation composition and process, the device and operating conditions, the patient–device relationship, the environmental variables, and ultimately, patient compliance.
May 28, 2015
By Pharmaceutical Technology Editors
Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or bipolar I disorder.
May 11, 2015
By Pharmaceutical Technology Editors
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
May 04, 2015
Pharmaceutical Technology
Advances in transdermal drug delivery, particularly with microneedles, are enabling a wider range of drugs to be delivered through the skin.
Apr 16, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The Ph. Eur. contemplates adding specifications for sub-visible particles in eye drops and eye lotions to its monograph.
Apr 13, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The license approval marks another milestone in Aptar Pharma’s ongoing service development to provide large-scale production services to customers.
Apr 10, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Aptar Pharma has partnered with Shanghai Sine Promod Pharmaceutical to develop and launch its new budesonide dry powder inhaler (DPI), which features Aptar Pharma’s user-friendly and cost-effective Twister DPI.
